A service of StreetInsider.com

Most Popular

AAPL 140.02
C 26.20
GOOG 408.49
BAC 27.40
RIMM 69.71

Recently Added

SLAT 0.67
LNT 25.80
NDN 26.28
HTD 10.23
AGCO 29.88

Gaining Speed

XYNH 0.01
SAPE 6.13
ACCP 2.20
SNRY 0.57
CSG 45.46
1.13 -0.05 (-4.35%) AKRX

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:1.13 Change:-0.05 (-4.35%) Prev Close:1.18 Open: 1.15 Days Range:0.92 – 1.17 52 Week Range: 0.73 - 5.63 Volume:1635783 P/E: N/A
EPS:-0.14

Member Comments

No member comments available for AKRX


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 07/03/09

Recent Alert on 06/17/09 at 9:56am
Akorn, Inc. (AKRX) Acquires Eli Lilly's (LLY) Capastat Sulfate

Akorn, Inc. (NASDAQ: AKRX) has entered into an agreement to acquire from Eli Lilly and Company (NYSE: LLY) all rights in the U.S. and Canada to manufacture, market and sell the lyophilized antibiotic Capastat(R) Sulfate (capreomycin for injection,... Read More

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 06/23/09 at 4:45am
Pequot Capital Sells the Bulk of Its Akorn Stake
Blog Posts on 11/24/08 at 4:25pm
Investing in India's Generic Drug Market
Blog Posts on 11/18/08 at 5:01am
Akorn, Inc. Q3 2008 Earnings Call Transcript
Blog Posts on 08/25/08 at 1:39pm
Akorn, Inc. Q2 2008 Earnings Call Transcript